ALTRIA GROUP INC (PHM7.DE) Stock Fundamental Analysis
FRA:PHM7 - Deutsche Boerse Ag - US02209S1033 - Common Stock - Currency: EUR
Overall PHM7 gets a fundamental rating of 6 out of 10. We evaluated PHM7 against 4 industry peers in the Tobacco industry. While PHM7 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PHM7 is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year PHM7 was profitable.
In the past year PHM7 had a positive cash flow from operations.
PHM7 had positive earnings in each of the past 5 years.
In the past 5 years PHM7 always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 28.48%, PHM7 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHM7 has a better Return On Invested Capital (36.74%) than 100.00% of its industry peers.
PHM7 had an Average Return On Invested Capital over the past 3 years of 34.24%. This is significantly above the industry average of 20.78%.
The last Return On Invested Capital (36.74%) for PHM7 is above the 3 year average (34.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.48% | ||
| ROE | N/A | ||
| ROIC | 36.74% |
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.24%
ROIC(5y)31.38%
1.3 Margins
Looking at the Profit Margin, with a value of 42.97%, PHM7 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHM7's Profit Margin has improved in the last couple of years.
PHM7's Operating Margin of 49.62% is amongst the best of the industry. PHM7 outperforms 100.00% of its industry peers.
PHM7's Operating Margin has improved in the last couple of years.
PHM7's Gross Margin of 60.40% is in line compared to the rest of the industry. PHM7 outperforms 50.00% of its industry peers.
PHM7's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 49.62% | ||
| PM (TTM) | 42.97% | ||
| GM | 60.4% |
OM growth 3Y2.47%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.41%
GM growth 5Y3.35%
2. Health
2.1 Basic Checks
PHM7 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for PHM7 has been reduced compared to 1 year ago.
Compared to 5 years ago, PHM7 has less shares outstanding
PHM7 has a worse debt/assets ratio than last year.
2.2 Solvency
PHM7 has an Altman-Z score of 4.49. This indicates that PHM7 is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.49, PHM7 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHM7 has a debt to FCF ratio of 3.08. This is a good value and a sign of high solvency as PHM7 would need 3.08 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.08, PHM7 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.08 | ||
| Altman-Z | 4.49 |
ROIC/WACC3.76
WACC9.78%
2.3 Liquidity
A Current Ratio of 0.57 indicates that PHM7 may have some problems paying its short term obligations.
The Current ratio of PHM7 (0.57) is worse than 75.00% of its industry peers.
PHM7 has a Quick Ratio of 0.57. This is a bad value and indicates that PHM7 is not financially healthy enough and could expect problems in meeting its short term obligations.
PHM7 has a better Quick ratio (0.47) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
PHM7 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.89%.
PHM7 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.03% yearly.
PHM7 shows a decrease in Revenue. In the last year, the revenue decreased by -2.63%.
The Revenue has been decreasing by -0.89% on average over the past years.
EPS 1Y (TTM)5.89%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%6.96%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%-4.2%
3.2 Future
The Earnings Per Share is expected to grow by 3.38% on average over the next years.
Based on estimates for the next years, PHM7 will show a small growth in Revenue. The Revenue will grow by 0.73% on average per year.
EPS Next Y8.22%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
EPS Next 5Y3.38%
Revenue Next Year-1.12%
Revenue Next 2Y-0.63%
Revenue Next 3Y-0.73%
Revenue Next 5Y0.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.54, which indicates a very decent valuation of PHM7.
PHM7's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of PHM7 to the average of the S&P500 Index (26.31), we can say PHM7 is valued rather cheaply.
The Price/Forward Earnings ratio is 10.57, which indicates a very decent valuation of PHM7.
The rest of the industry has a similar Price/Forward Earnings ratio as PHM7.
PHM7's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.54 | ||
| Fwd PE | 10.57 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHM7 is valued a bit cheaper than 75.00% of the companies in the same industry.
PHM7's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.98 | ||
| EV/EBITDA | 10.09 |
4.3 Compensation for Growth
PHM7's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHM7 may justify a higher PE ratio.
PEG (NY)1.4
PEG (5Y)2.86
EPS Next 2Y5.28%
EPS Next 3Y4.56%
5. Dividend
5.1 Amount
PHM7 has a Yearly Dividend Yield of 6.87%, which is a nice return.
PHM7's Dividend Yield is a higher than the industry average which is at 5.80.
PHM7's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.87% |
5.2 History
The dividend of PHM7 has a limited annual growth rate of 4.03%.
Dividend Growth(5Y)4.03%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
67.18% of the earnings are spent on dividend by PHM7. This is not a sustainable payout ratio.
PHM7's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP67.18%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
FRA:PHM7 (6/13/2025, 7:00:00 PM)
51.83
+0.51 (+0.99%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)
Earnings (Next)
Inst Owners61.16%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap87.31B
Analysts72.17
Price Target52 (0.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.87% |
Yearly Dividend3.47
Dividend Growth(5Y)4.03%
DP67.18%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.08%
Min EPS beat(2)-2.78%
Max EPS beat(2)0.61%
EPS beat(4)1
Avg EPS beat(4)-2.07%
Min EPS beat(4)-5.41%
Max EPS beat(4)0.61%
EPS beat(8)1
Avg EPS beat(8)-2.46%
EPS beat(12)1
Avg EPS beat(12)-2.69%
EPS beat(16)2
Avg EPS beat(16)-2.47%
Revenue beat(2)0
Avg Revenue beat(2)-3.36%
Min Revenue beat(2)-4.94%
Max Revenue beat(2)-1.77%
Revenue beat(4)0
Avg Revenue beat(4)-3.57%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-1.77%
Revenue beat(8)0
Avg Revenue beat(8)-3.63%
Revenue beat(12)4
Avg Revenue beat(12)2.55%
Revenue beat(16)8
Avg Revenue beat(16)6.85%
PT rev (1m)3.25%
PT rev (3m)-2.76%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)0.44%
EPS NY rev (1m)1.38%
EPS NY rev (3m)0.93%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.54 | ||
| Fwd PE | 10.57 | ||
| P/S | 4.27 | ||
| P/FCF | 11.98 | ||
| P/OCF | 11.78 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.09 |
EPS(TTM)4.49
EY8.66%
EPS(NY)4.9
Fwd EY9.46%
FCF(TTM)4.33
FCFY8.35%
OCF(TTM)4.4
OCFY8.49%
SpS12.14
BVpS-1.8
TBVpS-11.53
PEG (NY)1.4
PEG (5Y)2.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.48% | ||
| ROE | N/A | ||
| ROCE | 46.85% | ||
| ROIC | 36.74% | ||
| ROICexc | 45.27% | ||
| ROICexgc | 672.84% | ||
| OM | 49.62% | ||
| PM (TTM) | 42.97% | ||
| GM | 60.4% | ||
| FCFM | 35.66% |
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.24%
ROIC(5y)31.38%
ROICexc(3y)39.44%
ROICexc(5y)36.25%
ROICexgc(3y)239.58%
ROICexgc(5y)176.43%
ROCE(3y)43.65%
ROCE(5y)40%
ROICexcg growth 3Y38.27%
ROICexcg growth 5Y47.52%
ROICexc growth 3Y4.07%
ROICexc growth 5Y13.18%
OM growth 3Y2.47%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.41%
GM growth 5Y3.35%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.08 | ||
| Debt/EBITDA | 1.94 | ||
| Cap/Depr | 49.66% | ||
| Cap/Sales | 0.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.32% | ||
| Profit Quality | 82.98% | ||
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.47 | ||
| Altman-Z | 4.49 |
F-Score7
WACC9.78%
ROIC/WACC3.76
Cap/Depr(3y)70.81%
Cap/Depr(5y)74.31%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.75%
Profit Quality(3y)109.56%
Profit Quality(5y)169.16%
High Growth Momentum
Growth
EPS 1Y (TTM)5.89%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%6.96%
EPS Next Y8.22%
EPS Next 2Y5.28%
EPS Next 3Y4.56%
EPS Next 5Y3.38%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%-4.2%
Revenue Next Year-1.12%
Revenue Next 2Y-0.63%
Revenue Next 3Y-0.73%
Revenue Next 5Y0.73%
EBIT growth 1Y-0.23%
EBIT growth 3Y-0.22%
EBIT growth 5Y2.09%
EBIT Next Year5.6%
EBIT Next 3Y3.07%
EBIT Next 5Y1.64%
FCF growth 1Y6.3%
FCF growth 3Y1.5%
FCF growth 5Y2.55%
OCF growth 1Y5.28%
OCF growth 3Y1.36%
OCF growth 5Y2.24%